3. 2. 2025

Krka receives new S&P Global CSA Score

1 min. read

On 31 January 2025, Krka received a score of 56 (out of 100) in the 2024 S&P Global Corporate Sustainability Assessment. On 31 January 2025, Krka’s S&P Global CSA Score ranked among top 10% of companies in the pharmaceutical industry in the S&P Global Corporate Sustainability Assessment. The score represents a further improvement compared to 2023.

SPS1_CSA_Score_Graphic_2024_Krka 1-w825

The received independent score reaffirms the outlined direction of the Krka Group’s sustainable management practises and ESG governance, where we prioritise our social responsibility and care for the health and well-being of patients. We provide them with access to high-quality, safe and effective medicines produced to the highest standards of good manufacturing practise. In this process, we place significant emphasis on environmental protection and reducing our environmental impact. In the governance of the Krka Group, we adhere to the highest standards of business ethics, integrity and transparent operations.

The received score serves as both an encouragement and a commitment to further improve the sustainability practices in the Krka Group.